vs
Side-by-side financial comparison of Arcellx, Inc. (ACLX) and CRYO CELL INTERNATIONAL INC (CCEL). Click either name above to swap in a different company.
Arcellx, Inc. is the larger business by last-quarter revenue ($8.1M vs $7.8M, roughly 1.0× CRYO CELL INTERNATIONAL INC). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -766.0%, a 717.4% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -79.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-63.9M). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -24.6%).
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
ACLX vs CCEL — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $7.8M |
| Net Profit | $-62.3M | $-3.8M |
| Gross Margin | — | 77.9% |
| Operating Margin | -847.6% | -50.6% |
| Net Margin | -766.0% | -48.7% |
| Revenue YoY | -79.3% | -2.3% |
| Net Profit YoY | -765.1% | -105.1% |
| EPS (diluted) | $-1.13 | $-0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $7.8M | ||
| Q3 25 | — | $7.8M | ||
| Q2 25 | — | $7.9M | ||
| Q1 25 | $8.1M | $8.0M | ||
| Q4 24 | $15.3M | $8.0M | ||
| Q3 24 | $26.0M | $8.1M | ||
| Q2 24 | $27.4M | $8.0M | ||
| Q1 24 | $39.3M | $7.9M |
| Q4 25 | — | $-3.8M | ||
| Q3 25 | — | $749.4K | ||
| Q2 25 | — | $355.8K | ||
| Q1 25 | $-62.3M | $282.9K | ||
| Q4 24 | $-47.1M | $-1.9M | ||
| Q3 24 | $-25.9M | $1.1M | ||
| Q2 24 | $-27.2M | $655.8K | ||
| Q1 24 | $-7.2M | $556.2K |
| Q4 25 | — | 77.9% | ||
| Q3 25 | — | 77.0% | ||
| Q2 25 | — | 76.6% | ||
| Q1 25 | — | 75.1% | ||
| Q4 24 | — | 78.4% | ||
| Q3 24 | — | 73.6% | ||
| Q2 24 | — | 74.8% | ||
| Q1 24 | — | 73.7% |
| Q4 25 | — | -50.6% | ||
| Q3 25 | — | 24.3% | ||
| Q2 25 | — | 18.8% | ||
| Q1 25 | -847.6% | 13.3% | ||
| Q4 24 | -348.2% | -1.5% | ||
| Q3 24 | -129.1% | 17.2% | ||
| Q2 24 | -127.8% | 17.3% | ||
| Q1 24 | -40.3% | 10.5% |
| Q4 25 | — | -48.7% | ||
| Q3 25 | — | 9.6% | ||
| Q2 25 | — | 4.5% | ||
| Q1 25 | -766.0% | 3.5% | ||
| Q4 24 | -308.4% | -23.2% | ||
| Q3 24 | -99.4% | 13.0% | ||
| Q2 24 | -99.3% | 8.2% | ||
| Q1 24 | -18.3% | 7.1% |
| Q4 25 | — | $-0.46 | ||
| Q3 25 | — | $0.09 | ||
| Q2 25 | — | $0.04 | ||
| Q1 25 | $-1.13 | $0.03 | ||
| Q4 24 | $-0.87 | $-0.23 | ||
| Q3 24 | $-0.48 | $0.13 | ||
| Q2 24 | $-0.51 | $0.08 | ||
| Q1 24 | $-0.14 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $543.3M | $3.3M |
| Total DebtLower is stronger | — | $8.4M |
| Stockholders' EquityBook value | $416.9M | $-18.6M |
| Total Assets | $648.1M | $61.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.3M | ||
| Q3 25 | — | $3.2M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | $543.3M | $3.5M | ||
| Q4 24 | $587.4M | $3.5M | ||
| Q3 24 | $574.3M | $2.1M | ||
| Q2 24 | $516.7M | $1.5M | ||
| Q1 24 | $573.9M | $979.6K |
| Q4 25 | — | $8.4M | ||
| Q3 25 | — | $8.4M | ||
| Q2 25 | — | $8.4M | ||
| Q1 25 | — | $8.5M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $8.5M | ||
| Q2 24 | — | $8.5M | ||
| Q1 24 | — | $8.6M |
| Q4 25 | — | $-18.6M | ||
| Q3 25 | — | $-14.8M | ||
| Q2 25 | — | $-15.6M | ||
| Q1 25 | $416.9M | $-14.7M | ||
| Q4 24 | $454.8M | $-13.2M | ||
| Q3 24 | $483.0M | $-9.6M | ||
| Q2 24 | $487.2M | $-10.7M | ||
| Q1 24 | $496.6M | $-10.3M |
| Q4 25 | — | $61.7M | ||
| Q3 25 | — | $63.2M | ||
| Q2 25 | — | $64.4M | ||
| Q1 25 | $648.1M | $64.4M | ||
| Q4 24 | $711.3M | $64.7M | ||
| Q3 24 | $764.9M | $62.9M | ||
| Q2 24 | $734.3M | $62.6M | ||
| Q1 24 | $779.7M | $61.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.1M | $1.3M |
| Free Cash FlowOCF − Capex | $-63.9M | $1.2M |
| FCF MarginFCF / Revenue | -786.4% | 15.5% |
| Capex IntensityCapex / Revenue | 9.6% | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-122.5M | $5.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.3M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $707.0K | ||
| Q1 25 | $-63.1M | $954.1K | ||
| Q4 24 | $-46.0M | $2.2M | ||
| Q3 24 | $30.7M | $2.4M | ||
| Q2 24 | $-36.2M | $1.8M | ||
| Q1 24 | $-31.9M | $-356.9K |
| Q4 25 | — | $1.2M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $644.6K | ||
| Q1 25 | $-63.9M | $892.0K | ||
| Q4 24 | $-47.5M | $2.1M | ||
| Q3 24 | $28.4M | $2.3M | ||
| Q2 24 | $-39.5M | $21.5K | ||
| Q1 24 | $-38.3M | $-814.6K |
| Q4 25 | — | 15.5% | ||
| Q3 25 | — | 31.9% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | -786.4% | 11.2% | ||
| Q4 24 | -311.3% | 26.8% | ||
| Q3 24 | 109.2% | 27.9% | ||
| Q2 24 | -144.1% | 0.3% | ||
| Q1 24 | -97.7% | -10.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | 9.6% | 0.8% | ||
| Q4 24 | 9.8% | 0.1% | ||
| Q3 24 | 8.8% | 2.3% | ||
| Q2 24 | 11.7% | 21.8% | ||
| Q1 24 | 16.4% | 5.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.38× | ||
| Q2 25 | — | 1.99× | ||
| Q1 25 | — | 3.37× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.32× | ||
| Q2 24 | — | 2.70× | ||
| Q1 24 | — | -0.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
